Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study

BACKGROUND: Inflammatory processes are increased in the Parkinson's disease (PD) brain. The long-term use of nonsteroidal anti-inflammatory drugs has been associated, in retrospective studies, with decreased risk for PD, suggesting that inflammation may contribute to development of this disorde...

Descripción completa

Detalles Bibliográficos
Autores principales: Loeffler, David A, Camp, Dianne M, Conant, Stephanie B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626447/
https://www.ncbi.nlm.nih.gov/pubmed/17052351
http://dx.doi.org/10.1186/1742-2094-3-29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626447/
https://www.ncbi.nlm.nih.gov/pubmed/17052351
http://dx.doi.org/10.1186/1742-2094-3-29

Ejemplares similares